The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
作者信息
Diwan Abhinav
机构信息
Departments of Medicine, Cell Biology and Physiology, Obstetrics and Gynecology, and Neurology; Center for Cardiovascular Research; and Hope Center for Neurologic Disorders, Washington University School of Medicine, St Louis, MO. John Cochran Veterans Affairs Medical Center, St Louis, MO.
出版信息
Circulation. 2024 Sep 3;150(10):787-790. doi: 10.1161/CIRCULATIONAHA.124.070750.
Abstract
摘要
相似文献
1
The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?恢复细胞器以治疗缺血性心肌病的理由：DEPP1是一个有吸引力的靶点吗？
Circulation. 2024 Sep 3;150(10):787-790. doi: 10.1161/CIRCULATIONAHA.124.070750.
2
Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.低氧诱导因子介导 DEPP1 的诱导作用，从而介导缺血性心肌病的多种特征。
Circulation. 2024 Sep 3;150(10):770-786. doi: 10.1161/CIRCULATIONAHA.123.066628. Epub 2024 Jun 17.
3
SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.SPTLC3 对复合物 I 活性至关重要，并有助于缺血性心肌病。
Circulation. 2024 Aug 20;150(8):622-641. doi: 10.1161/CIRCULATIONAHA.123.066879. Epub 2024 Apr 25.
4
Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177 (Dapansutrile) in a Mouse Model of Severe Ischemic Cardiomyopathy Due to Non-Reperfused Anterior Wall Myocardial Infarction.在因未再灌注前壁心肌梗死导致的严重缺血性心肌病小鼠模型中，通过用OLT1177（达潘舒特rile）抑制NLRP3炎性小体来保留收缩储备和舒张功能。
Molecules. 2021 Jun 9;26(12):3534. doi: 10.3390/molecules26123534.
5
Using coronary calcification to exclude an ischemic etiology for cardiomyopathy: A validation study and systematic review.利用冠状动脉钙化排除心肌病的缺血性病因：一项验证性研究及系统评价
Int J Cardiol. 2017 Mar 1;230:518-522. doi: 10.1016/j.ijcard.2016.12.068. Epub 2016 Dec 20.
6
Identification of a key smooth muscle cell subset driving ischemic cardiomyopathy progression through single-cell RNA sequencing.通过单细胞RNA测序鉴定驱动缺血性心肌病进展的关键平滑肌细胞亚群。
Sci Rep. 2025 Jul 27;15(1):27331. doi: 10.1038/s41598-025-09928-6.
7
Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.他汀类药物用于缺血性和非缺血性心肌病患者的实验及临床依据。
J Am Coll Cardiol. 2008 Jan 29;51(4):415-26. doi: 10.1016/j.jacc.2007.10.009.
8
Effects of trimetazidine on cardiac function and ventricular remodeling in patients with ischemic cardiomyopathy: a systematic review and meta-analysis.曲美他嗪对缺血性心肌病患者心功能和心室重构的影响：一项系统评价和荟萃分析。
Gen Thorac Cardiovasc Surg. 2025 Jun 17. doi: 10.1007/s11748-025-02171-w.
9
Beyond conventional therapy: NOX4 as a promising target in cardiomyopathy.超越传统疗法：NOX4作为心肌病的一个有前景的靶点。
Mol Biol Rep. 2025 Jul 11;52(1):704. doi: 10.1007/s11033-025-10818-3.
10
Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias.雷诺嗪：治疗心肌缺血、心肌功能障碍及心律失常的新范例
Cardiol Clin. 2008 Nov;26(4):603-14. doi: 10.1016/j.ccl.2008.06.002.
本文引用的文献
1
Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.低氧诱导因子介导 DEPP1 的诱导作用，从而介导缺血性心肌病的多种特征。
Circulation. 2024 Sep 3;150(10):770-786. doi: 10.1161/CIRCULATIONAHA.123.066628. Epub 2024 Jun 17.
2
Role of lipids in interorganelle communication.脂质在细胞器间通讯中的作用。
Trends Cell Biol. 2025 Jan;35(1):46-58. doi: 10.1016/j.tcb.2024.04.008. Epub 2024 Jun 11.
3
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges.靶向低氧诱导因子：治疗机会与挑战。
Nat Rev Drug Discov. 2024 Mar;23(3):175-200. doi: 10.1038/s41573-023-00848-6. Epub 2023 Dec 20.
4
Brown Adipose Tissue and BMP3b Decrease Injury in Cardiac Ischemia-Reperfusion.棕色脂肪组织和 BMP3b 减少心脏缺血再灌注损伤。
Circ Res. 2023 Aug 4;133(4):353-365. doi: 10.1161/CIRCRESAHA.122.322337. Epub 2023 Jul 18.
5
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How.缺血性心肌病患者的心肌血运重建：适合哪些患者以及如何进行。
J Am Heart Assoc. 2023 Mar 21;12(6):e026943. doi: 10.1161/JAHA.122.026943. Epub 2023 Mar 9.
6
The Goldilocks Oxygen Principle: not too little and not too much.金凤花氧气原则：不多不少。
Nat Cardiovasc Res. 2022 Dec;1(12):1101-1103. doi: 10.1038/s44161-022-00178-7. Epub 2022 Dec 12.
7
BNIP3L/NIX regulates both mitophagy and pexophagy.BNIP3L/NIX 调节线粒体自噬和过氧化物酶体自噬。
EMBO J. 2022 Dec 15;41(24):e111115. doi: 10.15252/embj.2022111115. Epub 2022 Oct 10.
8
HIF in the heart: development, metabolism, ischemia, and atherosclerosis.心脏中的低氧诱导因子：发育、代谢、缺血和动脉粥样硬化。
J Clin Invest. 2021 Sep 1;131(17). doi: 10.1172/JCI137557.
9
Genetic Screen for Cell Fitness in High or Low Oxygen Highlights Mitochondrial and Lipid Metabolism.高或低氧条件下细胞适应性的遗传筛选凸显了线粒体和脂代谢。
Cell. 2020 Apr 30;181(3):716-727.e11. doi: 10.1016/j.cell.2020.03.029. Epub 2020 Apr 6.
10
A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy.冠状动脉内递送线粒体实现心肌保护的新型生物学策略：安全性与有效性
JACC Basic Transl Sci. 2019 Dec 23;4(8):871-888. doi: 10.1016/j.jacbts.2019.08.007. eCollection 2019 Dec.
Zotero 插件